Related Experiment Video
Updated: May 11, 2026

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
A stroke patient with persistently intermittent fever treated with gabapentin: A clinical case
Jingjie Huang1,2, Bangqi Wu2, Yupei Cheng1,2
1Degree: Postgraduate student, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Abstract:
Fever is one of the most common complications in stroke patients and can generally be classified as either infectious or non-infectious. Infectious fevers are commonly caused by pulmonary infections, urinary tract infections, and secondary infections associated with medical interventions such as endotracheal intubation, urinary catheterization, and nasogastric tubes. Non-infectious fevers primarily manifest as central fevers, although in rare cases, they may also result from drug-induced causes. Existing research indicates that the most common cause of central fever is brainstem hemorrhage, followed by hemorrhage in the basal ganglia and thalamus, then cerebellar hemorrhage, large cortical infarction, and basilar artery occlusion, with intraventricular hemorrhage being relatively rare. Stroke patients' body temperatures can rise to 39°C within 12 hours after onset and peak within 24 hours. In this case, a stroke patient with acute cerebral infarction and secondary thalamic hemorrhage developed new sensory abnormalities in the left limbs and intermittent fever during hospitalization. Despite the use of antibiotics targeting a pulmonary infection, the patient's fever did not show significant improvement. Gabapentin was added to the treatment regimen to address the sensory abnormalities. Surprisingly, within four hours of gabapentin administration, the patient's body temperature normalized and remained stable during subsequent monitoring. This observation led us to hypothesize that gabapentin may have a potential role in alleviating central fever.
Insights
Fever is common in stroke patients. A case study suggests Gabapentin may effectively reduce central fever in stroke patients, offering a new treatment possibility.
Area of Science:
- Neuroscience
- Clinical Neurology
- Pharmacology
Background:
- Fever is a frequent complication in stroke patients, categorized as infectious or non-infectious.
- Non-infectious fevers, or central fevers, are often linked to neurological damage, particularly brainstem or thalamic hemorrhages.
- Current treatments for stroke-related fever are often insufficient, especially for central fever.
Observation:
- A stroke patient with acute cerebral infarction and thalamic hemorrhage experienced persistent fever and sensory abnormalities.
- Antibiotic treatment for a suspected pulmonary infection failed to resolve the fever.
- The administration of Gabapentin for sensory abnormalities led to a rapid normalization of body temperature.
Findings:
- Gabapentin administration was associated with the resolution of fever in a stroke patient with central fever.
- The patient's temperature stabilized within four hours of receiving Gabapentin.
- This suggests a potential therapeutic role for Gabapentin in managing central fever post-stroke.
Implications:
- Gabapentin may represent a novel therapeutic option for managing central fever in stroke patients.
- Further research is warranted to confirm Gabapentin's efficacy and safety in treating central fever.
- This finding could lead to improved fever management strategies, potentially improving stroke patient outcomes.
More Related Videos
Related Concept Videos
Increased Body Temperature
Types of Fever
Here are the different types of fever:
Patterns of Fever
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction

